NCT01508117 Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients Status TERMINATED Phase PHASE2
NCT01478854 Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide Status COMPLETED Phase NA
NCT01478178 Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT01474239 A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma Status COMPLETED Phase PHASE2
NCT01470794 Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor Status COMPLETED Phase PHASE1
NCT01450449 Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme Status COMPLETED Phase PHASE3
NCT01435395 Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT01402063 PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation Status COMPLETED Phase PHASE2
NCT01386710 Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma Status SUSPENDED Phase PHASE1/PHASE2
NCT01353625 Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies. Status COMPLETED Phase PHASE1
NCT01351519 A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors Status TERMINATED Phase PHASE2
NCT01349660 Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme Status COMPLETED Phase PHASE1/PHASE2
NCT01317888 Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas Status UNKNOWN Phase NA
NCT01317212 Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme Status WITHDRAWN Phase PHASE1
NCT01308684 A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma Status COMPLETED Phase PHASE1
NCT01301430 Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme. Status COMPLETED Phase PHASE1/PHASE2
NCT01294735 Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1) Status COMPLETED Phase PHASE1